Why is Hester Bios falling/rising?

As of 23-Sep, Hester Biosciences Ltd is experiencing a decline in its stock price, currently at 1,973.00, reflecting a decrease of 10.55 or 0.53%. The stock has been on a downward trend, losing 4.32% over the past week and 2.28% over the past month. It has fallen for five consecutive days, and while it is trading above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages. Despite these declines, the company has shown strong financial performance, with a net profit growth of 145.1% and positive results for the last five consecutive quarters, which may provide some support for the stock amidst its recent price drop.
In the broader market context, Hester Biosciences' recent performance has been notably weaker than the benchmark Sensex, which has only declined by 0.34% over the past week and increased by 0.98% over the past month. Year-to-date, Hester's stock has decreased by 17.54%, while the Sensex has gained 5.07%. This stark contrast highlights the stock's underperformance relative to the market. However, the rising investor participation, indicated by a 28.81% increase in delivery volume, suggests that there may be interest in the stock despite its recent price movements. The liquidity of the stock also remains adequate for trading, which could indicate potential for recovery if market conditions improve.